Fredrik Debong

About

Fredrik Debong is a venture investor and startup ecosystem contributor serving as General Partner at 1921. He is best known as a Co-Founder of mySugr, a digital diabetes company acquired by Roche, and has continued building and backing startups in health and technology. With experience across multiple company creations, exits, and angel investments, Fredrik brings a founder-investor perspective on digital health, regulated markets, product adoption, scaling mission-driven companies, and what changes when a startup moves from early experimentation toward strategic acquisition or institutional growth. In practice, that perspective connects founder quality, market evidence, investment fit, and the long-term work required to build a company that investors can continue supporting. Fredrik is particularly relevant to conversations around fundraising readiness, investor decision-making, venture-scale growth, and the signals that help founders build conviction with capital partners.